Insulin resistance

16:13 - 22 May , 2021

Disease

What is Insulin resistance?

We speak of the pancreas inability to produce sufficient amounts of the hormone called insulin which helps cells absorb the blood sugar. Due to this decompensation, glucose levels rise, causing the appearance of metabolic diseases such as diabetes.

Potential causes and risks:

A high consumption of sugars and carbohydrates, being overweight, obese, and having a sedentary lifestyle, as well as a genetic predisposition to suffer from it, can contribute to its appearance.

Symptoms

At the beginning, insulin resistance does not generate specific symptoms, however, as the production of this hormone decreases and blood sugar levels increase, some signs may appear such as darkening in certain areas of the skin, excessive fatigue, and frequent urge to urinate, among others.

Diagnosis and treatment

To establish a proper diagnosis, it will be necessary to review your medical history and perform blood tests to measure your blood sugar levels.  The treatment to follow will depend on your case, but surely your doctor will indicate changes in your diet and physical activity so that you can lose weight. He or she could also prescribe medications that are meant to control your glucose levels. At the Nutrition & Obesity Center we offer you comprehensive care according to your needs to help you have a healthy lifestyle, control your weight, change your body composition, prevent and manage associated diseases, as well as improve your physical and sports performance. We have specialized schemes for accelerated and sustained weight loss under the supervision of a multidisciplinary team, based on safe and scientifically supported methods.

Fuentes: 

  • mayoclinic.org
  • cigna.com
  • sos-bariatria.com
  • medlineplus.gov
  • medigraphic.com
  • Bell J, George W, García M, Delgado E. Identificación del síndrome metabólico en pacientes con diabetes mellitus e hipertensión arterial. Medisan. 2017;21(10):23-28.
  • Feria DGE, Leyva PCA, Rodríguez RER, et al. Dislipidemia en estados de resistencia a la insulina. Correo Científico Médico. 2019;23(4).
  • González O, Arpa A G Herrera D. Valoración de la insulinorresistencia en pacientes con Síndrome metabólico. Rev Med Milit. 2013;14(2):23-30.
  • Hernández PG, Pérez BAM, Niño ES. Lipoproteínas, dislipidemia y resistencia a la insulina. Correo Científico Médico. 2019;23(3).
  • Tagi VM, Giannini C, Chiarelli F. Insulin Resistance in Children. Front Endocrinol (Lausanne). 2019; 10: 342. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558106/pdf/fendo-10-00342.pdf
The dissemination of the content of this material is for informational purposes only and does not replace, under any circumstance or condition, a consultation with a specialist doctor, for which the ABC Medical Center is not responsible for the different use that may be given to it. If you require more information related to the subject, we suggest you contact the specialist doctor you trust directly.